Search
+
    SEARCHED FOR:

    PHARMACEUTICAL EXPORTS INDIA

    For investors with long horizons and focus on underlying businesses: 5 mid- and small-cap stocks with upside potential of up to 34%

    Here’s one thing to remember: Be very careful when you use fresh money to average down a stock because it has fallen. Averaging is not a strategy if the original investment thesis has weakened. In many cases, the habit of averaging only increases the size of the eventual loss. Fresh capital deserves fresh ideas.

    Modi's grouse with India Inc explained: Why is it sitting on windfall?

    Prime Minister Narendra Modi addressed corporate India at FICCI’s convention, urging better response to government initiatives. He criticized industry for insufficient investment, despite tax cuts intended to stimulate growth. Modi emphasized the need for companies to enhance production and hire staff following these concessions. The speech highlighted that lower corporate taxes have not automatically translated into increased salaries or jobs.

    China using Pakistan, supply chains to constrain India’s rise: US Panel

    China is trying to restrict India's development by exerting military pressure along their disputed border and supporting Pakistan. The US-China Economic and Security Review Commission has warned that Beijing is using economic leverage to suppress India’s progress. While both nations showed signs of improved relations, China continues to expand its military infrastructure, creating ongoing threats. The report highlights the need for stronger India-US cooperation in defense and technology areas.

    West Bengal has the potential to emerge as a major manufacturing and export hub, says Primus Partners report

    By proposing measures to boost competitiveness and upgrade infrastructure, the study stresses the importance of strategic investments and nurturing a skilled workforce to harness the state’s varied industrial assets.

    India gets down to the nuts and bolts to give the world a taste of shuddh, Swadeshi quality

    India’s ambition to take Swadeshi products to global markets faces a critical test: quality. From ZED certification and mandatory product standards to export compliance support and sector-specific manufacturing incentives, the government has rolled out measures to improve competitiveness. Here is a look at the policy push to make Indian products world-class.

    India eyes $12 billion trade with Egypt, but exporters flag tariff and payment hurdles

    From cotton yarn, pharmaceuticals and speciality chemicals to engineering goods, EV charging and digital infrastructure, Indian businesses see growing opportunities in Egypt. But tariff disadvantages, regulatory hurdles, payment delays, logistics costs and Chinese competition could determine how much they gain.

    • Axis Bank expects MSME loan book to grow 25% in second half of FY27

      Axis Bank expects its micro, small and medium enterprises loan portfolio to grow significantly by 25%. The MSME loan book was reported at Rs 3.3 lakh crore as of September. Women borrowers comprise approximately 15% of the Bank’s MSME segment, with a goal to increase this share. The bank is addressing the financial needs of women entrepreneurs through its dedicated women's savings account ARISE.

      India can replicate pharma, IT success in emerging sectors to boost exports: Economist

      Naina Lal Kidwai highlighted India's ability to expand its export successes in emerging industries like electronics and defense. She emphasized the need for quality manufacturing that caters to both domestic and international markets. According to her, India should focus on import substitution to strengthen its industrial ecosystem. Kidwai also mentioned the impact of global crude prices on inflation within the Indian economy.

      Be cautiously optimistic, and focused on the medium term: 5 mid-cap stocks with upside potential of up to 28%

      As the mood of the market changes, the stance should be the same as what we have been advocating these past few weeks: Cautious optimism. The fear that was right for most of the last two years can come down a notch, because the market has earned that much. But shedding fear is not the same as dropping your guard.

      India Inc is roaring again, but who might spoil the profit party?

      September-quarter profits for Corporate India have significantly increased due to robust demand and industrial activity. Revenue growth reached its fastest pace in 16 quarters, reflecting ongoing economic resilience. Despite this, rising inflation poses challenges to margins and consumer purchasing power in the near future. Economists expect the impact of inflation on corporate profitability and investment decisions to remain critical.

      For investors with patience and ability to take moderate risk: 5 mid-cap stocks with upside potential of up to 26%

      For all those who have decided it is now time to turn bullish, here’s a small reminder: The past year has been a very tough one for mid-cap stocks. So, if this is the segment you are interested in, be calm and be prepared. Because panic and anxiety during a correction are the worst things for any investor with high exposure to mid-cap stocks.

      PM in Manila: Aligning act east, Indo-Pacific & MAHASAGAR policies

      Prime Minister Narendra Modi will visit Manila for the ASEAN Summit, focusing on strengthening India's partnerships. The growing competition in the Indo-Pacific requires ASEAN countries to seek reliable collaborations with India. Maritime cooperation, educational exchanges, and renewable energy initiatives are critical areas for future collaboration.

      Goyal in Egypt: Both sides to discuss increasing cooperation in infra, mnfg, logistics

      Commerce and Industry Minister Piyush Goyal will visit Egypt for two days to enhance trade relations. He will engage in discussions to facilitate business participation in each other's markets and review the progress of bilateral trade. Over 140 Indian business leaders will accompany him to explore opportunities in various sectors. Meetings with Egyptian officials and business representatives are scheduled to reinforce economic cooperation.

      FICCI calls for comprehensive India-Africa trade framework

      India and Africa are encouraged to develop a comprehensive trade arrangement to enhance economic cooperation. Ficci emphasizes the importance of a predictable framework to address trade barriers and promote investment. With the upcoming visit of Commerce Minister Piyush Goyal to Egypt, both regions aim to strengthen ties. Egypt's strategic location provides opportunities for Indian companies in various sectors.

      JioBlackRock Flexi Cap Fund exits ITC, BSE, MCX, TCS and 17 more, trim exposure in HDFC Bank, Adani Energy and 16 others

      JioBlackRock Flexi Cap Fund made notable exits from various stocks including ITC and Tata Consultancy Services. The fund also reduced its exposure in HDFC Bank and other stocks during October. Additionally, it added around 13 new stocks to its portfolio, enhancing diversity. Notably, the fund increased its holdings in Punjab National Bank and Bank of India significantly.

      Compulsory licensing of drugs only after exhausting all other measures: Department of Pharmaceuticals secretary Manoj Joshi

      The government plans to address the high costs of innovative medicines by first negotiating prices. Compulsory licensing will be considered only after other alternatives are exhausted. Trade margins on high-cost drugs are being examined to enhance affordability. Discussions are ongoing with pharmaceutical companies to improve access and affordability of patented drugs. The government is also working on initiatives to support the local pharmaceutical manufacturing sector.

      PLI schemes achieve 76% of investment target, 64% of production goal: Niti Aayog

      The production-linked incentive (PLI) scheme has achieved 76% of its investment target and 64% of its production target, with electronics, telecom and pharmaceuticals emerging as strong performers, Niti Aayog said. As of March 2026, the scheme had attracted ₹2.40 lakh crore in investments, generated production worth ₹22.66 lakh crore and created over 8.49 lakh jobs.

      Pharma & healthcare funds top mutual fund return charts with over 19% gains. Should investors invest now or wait for a correction?

      Pharma and healthcare mutual funds have topped return charts in 2026 with over 19% gains. While strong sector growth supports the outlook, experts caution against chasing the rally and advise investors to assess valuations, risks and portfolio exposure.

      India drawing up list of export snags in South Asia

      India is identifying regulatory and market-access barriers in seven South Asian countries to expand exports and reach its $1-trillion target. Merchandise exports to these markets fell 1.3% to $25.7 billion in FY26. The government is examining certification delays, tariffs and product standards while exploring opportunities in chemicals, pharmaceuticals and textiles.

      Q2 Earnings Scorecard: Which sectors outperformed and which fell behind?

      The September quarter results indicate strong revenue and profit growth in sectors like automobiles and banking. In contrast, sectors such as IT and pharmaceuticals showed weakness amid inflationary pressures. Automobile sector leaders like Maruti Suzuki and Bajaj Auto reported significant growth in sales and exports. L&T's orders surged, while the cement sector faced challenges with fluctuating prices.

      Time to be contrarian? Are analysts behind the curve? 5 stocks from two segments of the oil and gas space

      The tensions that drove oil higher are still lurking under the surface. A single statement, or a single strike, and they can surface again within days. Another round of trouble cannot be entirely ruled out. And if it comes and oil climbs again, much of the contrarian case we are making weakens with it. So the improvement is real, but it is not yet fully safe.

      PSBs, pharma and defence: HDFC Securities CEO names Samvat 2083’s dark horses

      HDFC Securities MD and CEO Dhiraj Relli identifies public sector banks, pharmaceuticals and defence as potential outperformers in Samvat 2083. He favours largecaps for valuation comfort, highlights selective stock opportunities and urges investors to prioritise earnings visibility and disciplined asset allocation.

      Pharma industry steps up API investments to cut import dependence, move up value chain

      India's pharmaceutical sector is shifting towards high-value medicines and reducing reliance on imports through local manufacturing. Investments in active pharmaceutical ingredients and advanced therapies are on the rise to meet new healthcare demands. Industry leaders highlight the significance of supply-chain resilience and advancements in manufacturing capabilities. Recent data indicates strong domestic market growth and increasing pharmaceutical exports.

      These large-, mid- and small-cap stocks have upside potential of up to 31% in 1 year, according to analysts

      In the last two years, the world has learnt that you can never quite predict what US President Trump will do next. Tomorrow, to pull attention one way or another, there could well be some more action against Iran, changing the mood again in a single afternoon. So, the improvement in sentiment is real, but it is also fragile.

      India-EU FTA to simplify and reinforce corporate cooperation, says Swedish Ambassador Petra Menander

      The proposed India-European Union Free Trade Agreement (FTA) will simplify and reinforce bilateral corporate collaboration, said Sweden's Ambassador to India Petra Menander, pointing to expanded opportunities for technology transfers and joint industrial initiatives.

      Diwali 2026: 77 stocks knock down D-St bears to deliver multibagger returns of up to 4,700% in a year

      With Diwali 2026 on the horizon, 77 stocks have thrived despite market fluctuations, marking exceptional returns. Mrugesh Trading showcases an astonishing gain of 4,657%, while Axis Solution follows closely with 1,081%. Other strong performers are Sterlite Technologies and Cupid, each demonstrating impressive growth. Analysts are hopeful for a market rebound thanks to falling crude oil prices, which could positively impact sectors such as automotive, capital goods, and pharmaceuticals.

      Short-term headwinds, yes; owning the ecosystem is better: 20 healthcare stocks with downside risk of 23% to upside potential of 41%

      The healthcare sector is under scrutiny. The issue is pricing: What medicines cost and on what hospitals and the rest of the health ecosystem charge. And both the government and the courts have stepped in. At one level, that is not entirely a bad thing. Check out Stock Reports Plus, powered by Refinitiv, for price targets of over 4,000 listed stocks along with detailed company analysis focusing on five key components – earnings, fundamentals, relative valuation, risk, and price momentum – to generate standardised scores. SR+ Reports is a complimentary offering to ETPrime members.

      Karnataka urges exporters to leverage FTAs to boost trade, target $1 trillion economy

      Karnataka's industries minister MB Patil has urged manufacturers and exporters to leverage free trade agreements effectively. The state has signed trade agreements with 38 countries, which could enhance market access for various products. This initiative is part of Karnataka's goal to achieve a $1 trillion economy in the future. Increasing foreign direct investment highlights the state's economic momentum and potential growth.

      India's pharma exports rise 4.9% to USD 16.14 bn in H1; shipments to Europe up nearly 10%: Pharmexcil

      India's pharmaceutical exports increased nearly 5 percent, reaching USD 16.13 billion in the first half of the fiscal year. Growth was driven by strong demand from Europe, ASEAN, and Latin America. Shipments included drug formulations, biologicals, bulk drugs, and surgical products. Exports to key regions, particularly Europe and ASEAN, rose significantly during this period. Industry leaders emphasized the need for India to enhance its pharmaceutical innovation and manufacturing capabilities.

      Load More
    The Economic Times
    BACK TO TOP